:

CEREBRAS SHARES FALL 10% ON WEAK 2026 OUTLOOK

INDUSTRY DESK1 MIN READ
TUE, JUN 23, 2026

■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE

Cerebras Systems shares dropped about 10% after the newly public chipmaker issued a 2026 sales forecast that fell short of investor expectations. The disappointing guidance suggests slower growth in the competitive AI data center chip market.

Cerebras went public amid significant enthusiasm around artificial intelligence infrastructure, with investors betting the company could capture meaningful market share from entrenched players like Nvidia. The 2026 revenue projection, however, signaled more modest growth trajectories than the market had anticipated. The stock decline reflects investor concerns about Cerebras's ability to scale production and secure major customers in the increasingly crowded AI chip sector. Competition from both established semiconductor manufacturers and well-funded startups has intensified as enterprises build out large language model infrastructure. Cerebras manufactures wafer-scale AI processors designed for data center workloads. The company faces a critical period in demonstrating it can convert technical advantages into market adoption and revenue growth at the scale investors expect from a publicly traded semiconductor firm.

■ SOURCES

Bloomberg TechBloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Colombian payments infrastructure startup Yuno secured $45 million in Series B funding led by Andreessen Horowitz and Tiger Global. The capital will fund global expansion and the company's path to profitability.

JUST NOWIndustry Desk

AI code review startup CodeRabbit secured $143 million in Series C funding co-led by Atomico and Smash, reaching a $1.5 billion valuation. The round comes less than a year after the company raised $60 million in Series B.

JUST NOWAI Desk

Skan AI, a startup building a "context graph of work" through enterprise software monitoring, secured $63 million in Series C funding co-led by Cathay Innovation and Dell.

2H AGOAI Desk

Paul Conyngham, an Australian entrepreneur who used ChatGPT and Grok to develop a personalized cancer vaccine for his own dog, has launched Gamgee. The startup will offer personalized mRNA cancer vaccines for canines, with plans to expand beyond pets.

2H AGOAI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.